Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2021-03-18

Clinical Trial Update: Ceftaroline Pharmacokinetics in Continuous Renal Replacement Therapy [Phase 4]

View source ↗

Summary

A Phase 4 trial update on how ceftaroline pharmacokinetics behave during continuous renal replacement therapy in critically ill patients with infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ceftaroline (ceftaroline fosamil)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Infection During Renal Replacement Therapy, Critically Ill | Phase 4 | Status: COMPLETED